|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-1031-2024 - BD BBL Sensi Disc Imipenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231644 and 231645®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1032-2024 - BD BBL Sensi Disc Levofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231705 and 231706®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1033-2024 - BD BBL Sensi Disc Meropenem- 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231703 and 231704®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1034-2024 - BD BBL Sensi Disc Minocycline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231250 and 231251®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1035-2024 - BD BBL Sensi Disc Moxifloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231758®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1036-2024 - BD BBL Sensi Disc Ofloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231672®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1037-2024 - BD BBL Sensi Disc Piperacillin/Tazobactam- 100/10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231691 and 231692®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1038-2024 - BD BBL Sensi Disc Rifampin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231541 and 231544®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1039-2024 - BD BBL Sensi Disc Sulfamethoxazole with Trimethoprim 23.75/1.25 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231536 and 231539®
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|
Z-1012-2024 - BD BBL Sensi Disc Ampicillin - 10 ®g, Catalog No. 230705 and 231264; 2 ®g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility testing.
|
2
|
02/08/2024
|
Becton Dickinson & Co.
|